Trial Profile
Prospective, Randomized Double-Blind Study Dose Determination of Intestinal Delayed Release Phosphatidylcholine in Chronic Active Ulcerative Pancolitis [Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2014
Price :
$35
*
At a glance
- Drugs Phosphatidylcholine (Primary)
- Indications Ulcerative colitis
- Focus Proof of concept; Therapeutic Use
- 29 Jun 2014 New trial record
- 27 Nov 2006